TABLE 3.
Phenotype description and numbers availability
Phenotype | Description | Enviro. | 2015 year class a | 2016 year class a | 2017 year class a | 2018 year class a | 2019 year class a | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Geno | Total | Geno | Total | Geno | Total | Geno | Total | Geno | ||||
AGD severity b |
AGD1 AGD2 AGD3 AGD4 AGD5 |
Visual gill score (0–5) | Marine |
36,135 23,442 31,912 8961 9569 |
1025 0 1954 0 0 |
40,865 23,442 36,209 10,679 9569 |
2865 0 2866 397 0 |
45,403 23,442 40,513 10,679 9569 |
3380 0 3381 397 0 |
50,240 23,442 43,669 10,679 9569 |
8204 0 5426 397 0 |
52,785 23,442 47,298 10,679 9569 |
10,653 0 9938 397 0 |
Flesh color | Astaxanthin content (mg/kg) | Marine | 8418 | 512 | 9724 | 1088 | 11,271 | 1470 | 12,442 | 1762 | 13,441 | 2757 | |
Flesh fat content | Percentage of fat in wet weight (%) | Marine | 8170 | 508 | 9442 | 1074 | 10,948 | 1448 | 12,119 | 1740 | 12,519 | 2138 | |
Harvest Weight | Head on gutted (HOG) weight (kg) | Marine | 11,852 | 514 | 13,156 | 1089 | 14,721 | 1476 | 15,892 | 1768 | 16,885 | 2757 | |
Maturation | Presence/absence of sexual maturity at 22 months | Marine | 29,973 | 1809 | 33,754 | 2721 | 37,912 | 3236 | 41,268 | 6583 | 45,097 | 10,252 | |
Fresh | 20,718 | 997 | 23,145 | 1919 | 25,572 | 2951 | 28,467 | 5836 | 31,315 | 8569 | |||
Weight at 23 months | Weight at 23 months | Marine | 27,985 | 1807 | 31,751 | 2719 | 35,907 | 3234 | 39,261 | 6579 | 43,089 | 10,247 | |
Fresh | 20,684 | 998 | 23,111 | 1920 | 25,538 | 2952 | 28,431 | 5835 | 31,279 | 8568 | |||
Weight at 30 months | Weight at 30 months | Marine | 11,838 | 514 | 13,142 | 1089 | 14,707 | 1476 | 15,878 | 1768 | 16,871 | 2757 | |
Fresh | 14,008 | 189 | 15,481 | 822 | 25,572 | 3234 | 17,201 | 1657 | 22,349 | 5697 | |||
Totals | No. of individuals | 65,492 | 2978 | 72,660 | 4815 | 79,631 | 6362 | 87,367 | 14,075 | 96,171 | 22,469 |
Abbreviation: AGD, amoebic gill disease.
The total number of phenotypes (Total) or number of phenotypes with associated genotypes (Geno) available for the GEBV run in the specified year.
Intially, there were up to 5 AGD measurements due to repeated infections; since 2010, there is typically two representing the severity of AGD at first infection and at summer (peak) infection.